Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis

By Fanny Petermann-Rocha, Viktoria Balntzi, S. Gray, J. Lara, F. Ho, J. Pell, C. Celis-Morales. Journal of Cachexia, Sarcopenia and Muscle, 2021

1,185 citations recorded by the source corpus.

Sarcopenia is defined as the loss of muscle mass and strength. Despite the seriousness of this disease, a single diagnostic criterion has not yet been established. Few studies have reported the prevalence of sarcopenia globally, and there is a high level of heterogeneity between studies, stemmed from the diagnostic criteria of sarcopenia and the target population. The aims of this systematic review and meta‐analysis were (i) to identify and summarize the diagnostic criteria used to define sarcopenia and severe sarcopenia and (ii) to estimate the global and region‐specific prevalence of sarcopenia and severe sarcopenia by sociodemographic factors.

Subfields: Geriatrics and Gerontology, Physiology

View Paper: https://www.semanticscholar.org/paper/062833f53fb433a62b1b32ac9d5e77c1b4ee5a3d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. S. Larsson
2. Shuai Yuan

Citations in the corpus

• Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. (2023, methodology): “Definition Data from Carvalho do Nascimento PR [13] Data from Petermann-Rocha F [14]”